Journal of Dermatological Treatment · 2016 · 58 citations · 32 references
Life SciencesDermatologyAllergyEarly DetectionHypersensitivityCorticosteroid TherapySkin CareAdherenceClinical Measurement ToolsDermatologic Corticosteroid TherapyTopical Corticosteroid PreparationsTreatment With Topical Corticosteroids
BACKGROUND: Concerns regarding topical corticosteroid (TCS) use, broadly known as "corticophobia", are highly prevalent among dermatology patients and often result in non-adherence to TCS. This non-adherence contributes to poor disease control and increased health care costs. However, it is unknown if assessment of these concerns might help to identify patients at risk of TCS-non-adherence. Clinical tools indicating non-adherence could be helpful to improve management of this patient group. OBJECTIVE: To assess whether the available tools for measuring concerns regarding corticosteroids, the TOPICOP scale and the 0-10 Visual Analogue Scale (VAS), could help to detect non-adherence to TCS. METHODS: In 75 patients with concerns regarding TCS use both the TOPICOP scale and VAS were anonymously assessed. A comparison was made between TCS-adherent and non-adherent patients regarding the intensity and characteristics of their concerns. RESULTS: The intensity and quality of the concerns varied broadly among the patients. When using the VAS, a score of ≥5 detected 87% of non-adherent patients. The answers to the TOPICOP scale did not discriminate non-adherent from adherent patients. CONCLUSION: Using the VAS to assess concerns to use TCS could help identify patients at risk of TCS-non-adherence and facilitate discussion with the patient about potential non-adherence in a more substantiated, non-judgemental way.
32
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Xavier Robin, Natacha Turck, Alexandre Hainard et al. · BMC Bioinformatics · 2011 · 14K citations · Full text
Lars Osterberg, Terrence F. Blaschke · New England Journal of Medicine · 2005 · 7.9K citations
Full Coverage for Preventive Medications after Myocardial Infarction
Niteesh K. Choudhry, Jerry Avorn, Robert J. Glynn et al. · New England Journal of Medicine · 2011 · 741 citations · Full text